Diaceutics partners with Targos, HistoCyte Labs on dx network

Create PDF

“Too many patients are still missing out on getting the right treatment at the right time due to inefficiencies in the testing ecosystem. These partnerships will enable the diagnostic testing standardization and training support needed at a global level to make precision medicine treatments accessible to every patient,” Karina Hjort, senior director of innovation at Diaceutics, said in a press release.

Targos and HistoCyte’s services will be made to a select number of laboratories within Diaceutics’ network of more than 2,500 labs. The pilot collaboration will focus on PD-L1 testing.